Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Hisun Pharmaceutical Technology is the primary research and development subsidiary of Zhejiang Hisun Pharmaceutical, one of China's largest pharmaceutical companies. Located in the Zhangjiang Hi-Tech Park, the center focuses on the discovery and development of innovative small molecule drugs and biologics across therapeutic areas such as oncology, cardiovascular diseases, and anti-infectives. The facility serves as a hub for high-end formulation development, chemical synthesis, and biological drug engineering. It plays a critical role in transitioning Hisun from a generic-focused manufacturer to an innovation-driven biopharmaceutical leader. The company leverages advanced technology platforms to support a robust pipeline of internal candidates and collaborative projects. Its operations are integrated with the parent company's extensive manufacturing and commercialization infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Hisun Pharmaceutical Technology.